Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-21-041930
Filing Date
2021-02-12
Accepted
2021-02-12 17:22:08
Documents
2
Group Members
NEW LEAF BIOPHARMA OPPORTUNITIES II, L.P.NEW LEAF BPO ASSOCIATES II, L.PNEW LEAF BPO MANAGEMENT II, L.L.C.NEW LEAF VENTURE ASSOCIATES III, L.P.NEW LEAF VENTURE MANAGEMENT III, L.L.C.RONALD M. HUNTVIJAY K. LATHI

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d126295dsc13da.htm SC 13D/A 157532
2 EX-99.A d126295dex99a.htm EX-99.A 13668
  Complete submission text file 0001193125-21-041930.txt   173245
Mailing Address C/O NEW LEAF VENTURE PARTNERS 7 TIMES SQUARE, SUITE 3502 NEW YORK NY 10036
Business Address C/O NEW LEAF VENTURE PARTNERS 7 TIMES SQUARE, SUITE 3502 NEW YORK NY 10036 646-871-6400
New Leaf Venture Management III, L.L.C. (Filed by) CIK: 0001625657 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address BLOCK 2 FLOOR 3, HARCOURT CENTRE HARCOURT STREET DUBLIN L2 2
Business Address BLOCK 2 FLOOR 3, HARCOURT CENTRE HARCOURT STREET DUBLIN L2 2 (872) 225-6077
Iterum Therapeutics plc (Subject) CIK: 0001659323 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90503 | Film No.: 21629819
SIC: 2834 Pharmaceutical Preparations